high Archives - Page 3 of 3 - Family Medicine News

The DES saga: Death risk high for young women exposed in utero

03.05.2018 Health Problems

A letter from three University of Chicago researchers in this week’s New England Journal of Medicine updates a 47-year-old series of reports on the risks of exposure during pregnancy to a supplement, diethylstilbestrol (DES), that was once widely used but since 1971 has been linked to a rare cancer: clear-cell adenocarcinoma of the vagina and cervix. In the May 3, […]

Can fish oil supplementation attenuate stress symptoms in high risk jobs?

19.04.2018 Health Problems

A study published in the current issue of Psychotherapy and Psychosomatics suggests a role for fish-oil supplementation in workers who perform very stressful jobs. There is growing attention being paid to fish oil as one of the promising supplementations to improve symptoms of posttraumatic stress disorder (PTSD) by facilitating hippocampal neurogenesis and clearance of fear memory. The purpose of this […]

Study finds high rates of type 1 diabetes near food swamps

17.04.2018 Health Problems

Hotspots of type 1 diabetes in New York City are found in food swamps, areas with a higher proportion of fast food restaurants, for children and adults with type 1 diabetes, according to a new study published in the Endocrine Society’s Journal of the Endocrine Society. Patients with type 1 and type 2 diabetes share the same problem of high […]

Punjab, India: Mass treatment of a population with chronic hepatitis C infection produces high rates of cure

12.04.2018 Health Problems

A large-scale study evaluating the feasibility of decentralized care and the provision of free direct-acting antiviral agents (DAAs) has reported high rates of cure among a population of almost 20,000 individuals completing treatment for hepatitis C virus (HCV) infection. The study conducted in Punjab, India, which was reported today at The International Liver Congress 2018 in Paris, France, validated the […]

In Europe, CHMP missed an opportunity for osteoporosis patients at high risk of fracture

05.04.2018 Health Problems

Experts from the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) regret the recent decision by the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) to reject the marketing application for abaloparatide, a potential new treatment option for postmenopausal women at high risk of […]

« 1 2 3